Effect of simvastatin on ejection fraction in cardiac transplant recipients

Effect of simvastatin on ejection fraction in cardiac transplant recipients

Our study suggests that simvastatin treatment is associated with improved EF in cardiac transplant recipients independent of effects attributable to the lipid profile.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 1996-12, Vol.78 (12), p.1453-1456
Hauptverfasser: Jenkins, Geraint H., Grieve, Lesley A., Yacoub, Magdi H., Singer, Donald R.J.
Format: Artikel
Sprache:eng
Schlagworte:
Biological and medical sciences
Blood pressure
Blood Pressure - drug effects
Calcium Channel Blockers - pharmacology
Calcium Channel Blockers - therapeutic use
Drug therapy
Echocardiography
Female
General and cellular metabolism. Vitamins
Heart
Heart - drug effects
Heart Transplantation - physiology
Humans
Hypolipidemic Agents - pharmacology
Hypolipidemic Agents - therapeutic use
Lipids
Lovastatin - analogs & derivatives
Lovastatin - pharmacology
Lovastatin - therapeutic use
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Prospective Studies
Simvastatin
Stroke Volume - drug effects
Transplants & implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Our study suggests that simvastatin treatment is associated with improved EF in cardiac transplant recipients independent of effects attributable to the lipid profile.
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(96)00637-6